Histone Deacetylase Inhibitors as Cancer Therapeutics

<ol> <ol> <ol> <li>Histone Deacetylase Inhibitors Disrupt the Mitotic Spindle Assembly Checkpoint by Targeting Histone and Non-Histone Proteins<br></li> <li>Mechanisms of Resistance to Histone Deacetylase Inhibitors</li> <li>HDAC Inhibitors: Roles of DNA Damage and Repair</li> <li>HDAC Inhibitor Modulation of Proteotoxicity as a Therapeutic Approach in Cancer</li> <li>Intrinsic and Extrinsic Apoptotic Pathway Signaling as Determinants of Histone Deacetylase Inhibitor Anti-Tumor Activity</li> <li>Histone Deacetylase Inhibitors and Rational Combination Therapies</li> <li>HDAC Inhibitors and Chaperone Function</li> </ol> <p> </p></ol></ol>